NLS PHARMACEUTICS LTD (NLSP)
CH0523961370 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.47M | -16.50M | -11.95M | -2.86M | -5.45M | |||
| Depreciation Amortization | 5.70K | 10.00K | 10.00K | N/A | N/A | |||
| Change In Working Capital | 915.42K | 1.63M | -3.17M | 2.06M | 4.12M | |||
| Interest Paid | N/A | 10.00K | 340.00K | N/A | N/A | |||
| Other non cash items | 1.04M | 980.00K | 170.00K | 70.00K | 1.14M | |||
| OPERATING CASH FLOW | -13.51M | -13.88M | -14.94M | -730.00K | -190.00K | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | 0.00 | -40.00K | N/A | N/A | |||
| INVESTING CASH FLOW | N/A | 0.00 | -40.00K | N/A | N/A | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.18M | 830.00K | -2.10M | 1.19M | 670.00K | |||
| Stock Issued/Repurchased | 12.63M | 16.57M | 22.44M | N/A | N/A | |||
| Other Financing Activity | N/A | 0.00 | 0.00 | -690.00K | -260.00K | |||
| FINANCING CASH FLOW | 13.81M | 17.40M | 20.34M | 500.00K | 410.00K | |||
| Exchange Rate Effect | -420.00 | 0.00 | -20.00K | 100.00K | 0.00 | |||
| CHANGE IN CASH | 303.05K | 3.52M | 5.34M | -130.00K | 210.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -13.51M | -13.88M | -14.94M | -730.00K | -190.00K | |||
| Capital Expenditure | N/A | 0.00 | -40.00K | N/A | N/A | |||
| FREE CASH FLOW | -13.51M | -13.88M | -14.98M | -730.00K | -190.00K | |||
All data in USD